Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 12 % of short-term debt in 2024; threshold 65 %.
Financials
Financial year 2024
PRIMROSE LABORATORIES from Torhout, company number BE0879952227, closed financial year 2024 with a result of € 23,859 after tax. For that financial year PRIMROSE LABORATORIES recorded a gross margin of € 436,874 and equity of € -1.4 million. Compared with financial year 2023, the result moved from € -8,638 to € 23,859. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 8, 2025.
€ -1.4 million
▲ € 23,859 vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 23,859
▲ still € 8,638 loss in 2023
Profit after tax over the fiscal year.
€ 112
▼ 91% vs 2023
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2024. Retained profit grew to € -5.2 million.
People and assets in 2024
5.2
▲ 0.5 vs 2023
Average over the fiscal year, from the social balance sheet.
€ 303,064
▲ 30% vs 2023
€ 58,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,274
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 962,934
▼ 12% vs 2023
€ 145,434 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 139,579
▲ 29% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 138,254
▲ 52% vs 2023
Taxes, VAT and social contributions still to pay.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 199,143 | € 437,102 | € 346,127 | € 436,874 | ▲ 26% |
| Profit after taxes | € -187,642 | € 78,711 | € -8,638 | € 23,859 | ▲ € 32,497 |
| Equity | € -1,516,970 | € -1,438,259 | € -1,446,897 | € -1,423,038 | ▲ € 23,859 |
| Total debts | € 3,340,609 | € 3,374,753 | € 3,333,368 | € 3,325,979 | |
| Cash | € 72 | € 41 | € 1,201 | € 112 | ▼ 91% |
| Land & buildings | € 3,892 | € 2,618 | € 1,344 | € 70 | ▼ 95% |
| Retained profit | € -5,266,970 | € -5,188,259 | € -5,196,897 | € -5,173,038 | |
| Bank debt | € 1,218,010 | € 1,170,050 | € 1,092,822 | € 962,934 | ▼ 12% |
| Balance sheet total | € 1,823,639 | € 1,936,494 | € 1,886,471 | € 1,902,940 | ▲ 1% |
| Employees (FTE) | 4.3 | 4 | 4.7 | 5.2 | ▲ 0.5 |
Key figures of PRIMROSE LABORATORIES, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to PRIMROSE LABORATORIES?
What happened at PRIMROSE LABORATORIES in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 23,859. filed late Source: NBB ↗
- New establishment in Torhout. KBO
- Jacques Tavernier became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 187,642 loss in 2021 to € 23,859 profit in 2024.
Paid € 109 in corporate taxes since 2021.
Best year ever: 2022, with € 78,711 profit.
On average € 84,000 of value added per employee in 2024.
Management
The stake of SEA-HORSE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PRIMROSE LABORATORIESBehind PRIMROSE LABORATORIES is Jacques Tavernier. The shares are held by SEA-HORSE (33%). It owns 98.3% of Primrose Farma Belgica itself.
Directors
According to the 2024 annual accounts
since 2006
Shareholders
33%
Participations
98.3%
Establishments
Establishment units
Physical locations of this company
Kwaplasstraat 71
8820 Torhout
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.
All companies at this address →DERTA same network
€ 63,723 gross margin · 2025
LABORA
€ 42,989 gross margin · 2024
Vita Mina
€ 22,929 gross margin · 2024
PRIMROSE INVEST I same network
€ -1,171 gross margin · 2024
PRIMROSE FARMA BELGICA same network
€ 381,888 gross margin · 2024
+1 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0879.952.227
- VAT number
- BE 0879.952.227
- Registered office
- Kwaplasstraat 71, 8820 Torhout
- Names & denominations
- PRIMROSE LABORATORIES
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 14 March 2006
- Peppol
- Active · Active since 23 Sept 2025
- Activities · NACE
Vervaardiging van andere chemische producten, neg
Vervaardiging van etherische oliën
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen
Detailhandel in medische en orthopedische artikelen
Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels